A partir de cette page vous pouvez :
Retourner au premier écran avec les dernières notices... |
Détail de l'auteur
Auteur Audina M. Berrocal
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Affiner la rechercheCase Report: Endogenous Candida Endophthalmitis in Cornelia de Lange Syndrome: Atypical Stellate Neuroretinitis / Sophia El Hamichi in OVS : Optometry & Vision Science, vol. 98, 02 (Février 2021)
[article]
in OVS : Optometry & Vision Science > vol. 98, 02 (Février 2021)
Titre : Case Report: Endogenous Candida Endophthalmitis in Cornelia de Lange Syndrome: Atypical Stellate Neuroretinitis Type de document : article de périodique Auteurs : Sophia El Hamichi ; Veronica Kon Graversen ; Aaron Gold ; Audina M. Berrocal ; Timothy Murray Année de publication : 2021 Langues : Français (fre) Descripteurs (mots clés) : [Thésaurus Mesh]:S:Syndrome de Cornelia de Lange:Syndrome de Cornelia de Lange / complications
[Thésaurus Mesh]Candida
[Thésaurus Mesh]Infection
[Thésaurus Mesh]Maladies de l'oeil
[Thésaurus Mesh]Syndrome de Cornelia de LangeMots-clés : neurorétinite stellaire secondaire endophtalmie Résumé : SIGNIFICANCE
This study aimed to highlight the association of stellate neuroretinitis occurring secondary to endogenous candidemia.
PURPOSE
We report an unusual presentation of endogenous Candida endophthalmitis as a stellate neuroretinitis in the setting of Cornelia de Lange syndrome.
CASE REPORT
A 34-month-old girl with severe Cornelia de Lange syndrome and a history of parenteral nutrition dependence requiring a chronic central venous catheter presented with bilateral endophthalmitis secondary to candidemia. In one eye, the endophthalmitis had the atypical presentation as a stellate neuroretinitis.
CONCLUSIONS
This case represents a unique association of stellate neuroretinitis secondary to Candida infection in a patient with Cornelia de Lange syndrome.
Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Small Full-thickness Macular Hole Treated with Topical Dorzolamide and Bevacizumab Intravitreal Injections / Estephania Feria Anzaldo in OVS : Optometry & Vision Science, vol. 98,12 (Décembre 2021)
[article]
in OVS : Optometry & Vision Science > vol. 98,12 (Décembre 2021)
Titre : Small Full-thickness Macular Hole Treated with Topical Dorzolamide and Bevacizumab Intravitreal Injections Type de document : article de périodique Auteurs : Estephania Feria Anzaldo ; Sophia El Hamichi ; Aaron Gold ; Azeema Latiff ; Audina M. Berrocal ; Timothy Murray Année de publication : 2021 Langues : Français (fre) Descripteurs (mots clés) : [Thésaurus Mesh]:P:Perforations de la rétine:Perforations de la rétine / thérapie
[Thésaurus Mesh]Bévacizumab
[Thésaurus Mesh]Macula
[Thésaurus Mesh]Perforations de la rétineMots-clés : dorzolamide topique Résumé : SIGNIFICANCE
This article reports two cases reported of combined treatment with topical dorzolamide and intravitreal bevacizumab injections, successfully treating small full-thickness macular hole without the need for traditional macular hole surgery.
PURPOSE
This study aimed to report the potential effectiveness of combination treatment with topical dorzolamide and bevacizumab intravitreal injection therapy for small macular holes.
CASE REPORTS
Case 1 was a 68-year-old woman presented with distorted and decreased vision in her right eye for 9 months. Fundus examination showed a full-thickness macular hole, which was confirmed with spectral domain optical coherence tomography measuring 96 μm. Treatment with topical dorzolamide and intravitreal bevacizumab 1.25 mg/0.05 mL injections was initiated. Spectral domain optical coherence tomography showed gradual improvement of the full-thickness macular hole with complete hole closure and visual improvement in just 1 month. Case 2 was a 73-year-old woman who presented with distorted and decreased vision in her right eye for 8 months. Fundus examination showed a full-thickness macular hole in the right eye, confirmed with spectral domain optical coherence tomography, measuring 76 μm. Treatment with topical dorzolamide and intravitreal bevacizumab 1.25 mg/0.05 mL injections was initiated. Spectral domain optical coherence tomography showed gradual improvement of the full-thickness macular hole with complete closure at 2 months and improvement in visual acuity.
CONCLUSIONS
The combination of topical dorzolamide and bevacizumab intravitreal injection is a reasonable consideration for small macular holes with vascular components before considering surgery. Both cases had early macular closure in less than 3 months.Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire